Pricing Log in Create free account

Rallybio Corporation (RLYB) vs VAXART, INC. (VXRT)

Rallybio Corporation and VAXART, INC. are both Biotechnology companies. Rallybio Corporation and VAXART, INC. are of similar size ($92.4M and $90.2M). Rallybio Corporation trades at the lower P/E: 2.1× against 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against 1.18%. VAXART, INC. has the higher net margin (15.9% vs 0.00%) and the higher return on invested capital (134.6% vs −1,052.0%). Across the 17 metrics below, VAXART, INC. leads on 12 and Rallybio Corporation on 5.

Valuation

Metric RLYB VXRT Biotechnology median
P/E 2.11 2.75 8.68
P/S 113.05 0.44 10.29
P/B 1.03 1.29 2.40
Price to free cash flow 3.64 3.19 20.52
EV/EBITDA n/m 0.96 0.68
EV/Sales 4.83 0.18 10.15
Earnings yield 47.35% 36.36% (28.86%)
Free cash flow yield 27.51% 31.35% (22.44%)

Profitability

Metric RLYB VXRT Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 16.30% 0.00%
Net margin 0.00% 15.88% 0.00%
Free cash flow margin 0.00% 13.74% 0.00%
Return on equity 64.86% 66.97% (56.66%)
Return on assets 61.12% 23.44% (49.22%)
Return on invested capital (1,052.03%) 134.59% 0.00%

Growth

Metric RLYB VXRT Biotechnology median
Revenue growth (TTM) 1.18% 201.10% 5.64%
EPS growth (last fiscal year) 85.06% 121.21% 30.08%
Revenue growth, 5-year CAGR — 125.76% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLYB VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 27.26 1.60 4.72
Net debt to EBITDA 1.63 (2.42) 0.96

Dividend

Metric RLYB VXRT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric RLYB VXRT Biotechnology median
Market cap 90.23m 92.41m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack